Status:
UNKNOWN
Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Mycobacterium Pulmonary Infection
Eligibility:
All Genders
16-70 years
Brief Summary
Comparison of rapid detection methods of mycobacterial pathogens, GenSeizer v.s. PCR reverse hybridization.
Detailed Description
The investigators developed a new platform called GenSeizer, which combines bioinformatics analysis of a large dataset with multiplex PCR-based targeted gene sequencing, to identify eleven major Mycob...
Eligibility Criteria
Inclusion
- Suspected cases of mycobacterial lung infection
Exclusion
- No sputum
- Refused or unable to tolerate bronchoscopy
Key Trial Info
Start Date :
June 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04345939
Start Date
June 28 2021
End Date
August 30 2024
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haiqing Chu
Shanghai, China